Cita APA (7a ed.)
Hanauer, S. B. (2018). Safety and Positioning of Vedolizumab in Patients With Inflammatory Bowel Disease...Brian Feagan. Gastroenterology & Hepatology, 14(4), 244-247.
Cita Chicago Style (17a ed.)
Hanauer, Stephen B. "Safety and Positioning of Vedolizumab in Patients With Inflammatory Bowel Disease...Brian Feagan." Gastroenterology & Hepatology 14, no. 4 (2018): 244-247.
Cita MLA (9a ed.)
Hanauer, Stephen B. "Safety and Positioning of Vedolizumab in Patients With Inflammatory Bowel Disease...Brian Feagan." Gastroenterology & Hepatology, vol. 14, no. 4, 2018, pp. 244-247.
Precaución: Estas citas no son 100% exactas.